The top pharmacy benefit manager (PBM) in the U.S., CVS Caremark, will
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
CVS Caremark to cover Foundayo, Zepbound obesity drugs - UPI.com
CVS Caremark adds Zepbound and Foundayo to formulary
CVS obesity drug deal puts Lilly on equal footing with Novo
CVS expands access to blockbuster weight-drugs in surprise reversal
Lilly's Foundayo and Zepbound to gain CVS coverage, lifting sales outlook
CVS Caremark will cover Lilly’s weight loss drug Zepbound once again
CVS Caremark Delivers Affordability and Access to GLP-1 Weight Management Medications with Expanded Coverage Options
CVS sues to challenge Tennessee's new PBM law
Foundayo and Zepbound now covered for millions of Americans
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.
CVS Caremark will start covering Eli Lilly's Foundayo and resume covering its Zepbound obesity drugs in the next several months,…
The pharmacy benefit manager dropped Zepbound a year ago in favor of rival Wegovy — now both Lilly and Novo Nordisk drugs will be…
The agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for…
This move marks a pivotal shift for patients seeking access to these highly sought-after treatments
Lilly's Foundayo and Zepbound gain CVS Caremark formulary coverage, expanding access for 90 million members at $25 monthly…
